AstraZeneca PLC (AZN) Announces New $500 Million Cambridge Biomedical Campus HQ, Will Employ 2000 by 2016
6/18/2013 7:06:18 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Pharmaceutical giant AstraZeneca has announced it is setting up its new global headquarters at the Cambridge Biomedical Campus. The £330m research and development (R&D) site is expected to employ about 2,000 people and open by 2016. The company will cease R&D at Alderley Park in Cheshire and close its London HQ. The majority of posts will move to Cambridge, but 700 jobs are being axed. The new site will become AstraZeneca's largest centre for cancer research. It will also focus on cardiovascular, metabolic, respiratory, inflammation and autoimmune disease research.
Help employers find you! Check out all the jobs and post your resume.